RR

Russell P. Rother

AP Alexion Pharmaceuticals: 36 patents #1 of 226Top 1%
OF Oklahoma Medical Research Foundation: 2 patents #57 of 184Top 35%
SP Selexys Pharmaceuticals: 2 patents #5 of 5Top 100%
📍 Oklahoma City, OK: #7 of 1,463 inventorsTop 1%
🗺 Oklahoma: #140 of 12,736 inventorsTop 2%
Overall (All Time): #85,963 of 4,157,543Top 3%
38
Patents All Time

Issued Patents All Time

Showing 26–38 of 38 patents

Patent #TitleCo-InventorsDate
8637014 Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses Susan Faas McKnight 2014-01-28
8282924 Hybrid antibodies Dayang Wu 2012-10-09
8252285 Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses Susan Faas McKnight 2012-08-28
8067167 Hybrid antibodies Dayang Wu 2011-11-29
7927817 Hybrid antibodies Dayang Wu 2011-04-19
7399594 Hybrid antibodies Dayang Wu 2008-07-15
7393648 Hybrid antibodies Dayang Wu 2008-07-01
6355245 C5-specific antibodies for the treatment of inflammatory diseases Mark Evans, Louis A. Matis, Eileen Elliott Mueller, Steven H. Nye, Scott Rollins +4 more 2002-03-12
6040428 Porcine E-selectin Scott Rollins, Louis A. Matis, Mark Evans 2000-03-21
5891645 Porcine E-selectin Scott Rollins, Louis A. Matis, Mark Evans 1999-04-06
5871997 Methods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopes Scott Rollins, William Fodor, Jeremy P. Springhorn, Stephen P. Squinto 1999-02-16
5847082 Terminal complement inhibitor fusion proteins Scott Rollins, Stephen P. Squinto 1998-12-08
5562904 Retroviral transduction of cells using soluble complement inhibitors Scott Rollins, James M. Mason, Stephen P. Squinto 1996-10-08